Fluorodopa Production Cost Reports

The report provides a detailed analysis essential for establishing a Fluorodopa production plant. It encompasses all critical aspects necessary for Fluorodopa production, including the cost of Fluorodopa production, Fluorodopa plant cost, Fluorodopa production costs, and the overall Fluorodopa production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Fluorodopa production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Fluorodopa is a specialised pharmaceutical compound mainly used in the medical and diagnostic fields. It is widely used as a radiopharmaceutical in positron emission tomography scans to study brain function, especially for the diagnosis and evaluation of Parkinson’s disease and other neurological disorders. The compound helps assess dopamine activity in the brain by highlighting areas with reduced dopamine synthesis. It is also used in oncology imaging to detect and evaluate certain neuroendocrine tumours due to its uptake in metabolically active cells. Moreover, it also plays an important role in clinical research, supporting studies related to neurological diseases, tumour metabolism, and the development of advanced imaging techniques.

The market for Fluorodopa is predominantly driven by its application as a diagnostic aid in detecting and studying disorders related to the brain, which supports its demand in the medical sector. Its application as a radioactive agent in hospitals and diagnostic centres for detecting Parkinson’s disease and certain types of tumours also boosts its demand in the medical and healthcare sectors. Its application as a radiopharmaceutical compound in the detection of neuroendocrine tumours, including pheochromocytoma and paraganglioma, also fuels its demand in the medical and diagnostic sectors.

Its usage in PET (positron emission tomography) to highlight abnormal activity in the brain and other organs and provide valuable support in diagnosis and treatment planning further boosts its market growth. Industrial Fluorodopa procurement is influenced by factors like the availability of medical-grade raw materials, compliance with strict regulatory standards, and the need for high-purity production. The short shelf life of the product, specialised production facilities, and reliable cold-chain logistics also play a crucial role in shaping procurement decisions. Growth in advanced imaging infrastructure and rising focus on early and accurate disease diagnosis further contribute to the steady demand for Fluorodopa in global medical markets.

Raw Material for Fluorodopa Production

According to the Fluorodopa production plant project report, the major raw materials for Fluorodopa production include Mercury-substituted dopa derivative, Acetyl Hypofluorite, and Hydriodic Acid.

Production Process of Fluorodopa

The extensive Fluorodopa production cost report consists of the following industrial production process:

1. Production via Chemical Synthesis: The production process of Fluorodopa begins with the preparation of a mercury-substituted dopa derivative, which serves as the main starting material for introducing the radioactive fluorine atom. This intermediate reacts with acetyl hypofluorite, which allows the fluorine-18 isotope to be incorporated into the dopa structure. After the fluorination step, the reaction mixture is passed through a mercaptan-modified silica gel to effectively remove mercury residues and related by-products. Then, the solvent is removed, and the remaining material is treated with hydriodic acid to complete deprotection and finalise the molecular structure. The crude product is further purified using high-performance liquid chromatography to obtain Fluorodopa in a chemically and radiochemically pure form as the final product.

Fluorodopa is also known as 6-fluoro-L-3,4-dihydroxyphenylalanine. It is a fluorinated analogue of L-DOPA and is primarily used as a diagnostic agent in neurological and oncological imaging. It appears as a white to off-white crystalline powder and is generally odourless in its solid form. The molecular formula of the compound is C9H10FNO4, and its molar mass is approximately 215.8 g/mol. The compound is freely soluble in water due to the presence of polar functional groups, including hydroxyl and amino groups, and it also shows solubility in dilute acids. The melting point of fluorodopa is in the range of about 280 degree Celsius with decomposition. The compound is stable under controlled storage conditions but is sensitive to light and oxidation. It should be handled with appropriate care to avoid unnecessary exposure, as it is a biologically active compound.